BRD2 and ovarian hyperstimulation syndrome: Because these cases were included in Group A, the mean total FSH dose in Group A was lower than in Group B and a little higher than in Group C. In addition, in order to prevent OHSS, we also reduced the gonadotropins dose in high-ovarian-reserve patients (Group C).